Early research (Phase 1)Study completedNCT03718884What this trial is testingMirikizumab in Participants With Plaque PsoriasisWho this might be right forPsoriasis Eli Lilly and Company 29
Large-scale testing (Phase 3)Study completedNCT03073200What this trial is testingStudy of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Eli Lilly and Company 201
Large-scale testing (Phase 3)Study completedNCT03090100What this trial is testingEvaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type PsoriasisWho this might be right forPsoriasis Janssen Research & Development, LLC 1,048
Not applicableNot Yet RecruitingNCT07190391What this trial is testingPhase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe PsoriasisWho this might be right forPsoriasis Daewoong Pharmaceutical Co. LTD. 425
Post-approval studies (Phase 4)WithdrawnNCT00832364What this trial is testingTrial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type PsoriasisWho this might be right forPlaque Psoriasis Stiefel, a GSK Company
Large-scale testing (Phase 3)Study completedNCT03123471What this trial is testingThe Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the ScalpWho this might be right forPsoriasis Amgen 303
Testing effectiveness (Phase 2)Study completedNCT01018134What this trial is testingDesoximetasone Spray 0.05%, 0.25%; Dose Ranging StudyWho this might be right forPsoriasis Sun Pharmaceutical Industries, Inc. 151
Large-scale testing (Phase 3)Study completedNCT00195676What this trial is testingEfficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Abbott 1,469
Large-scale testing (Phase 3)Looking for participantsNCT07362017What this trial is testingOpen Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque PsoriasisWho this might be right forModerate-to-severe Chronic Plaque Psoriasis Vanda Pharmaceuticals 300
Large-scale testing (Phase 3)UnknownNCT03927352What this trial is testingThe Purpose of This Research Study is to Compare the Efficacy and Safety of SCT630 and Adalimumab (HUMIRA®) in Adults With Plaque PsoriasisWho this might be right forPsoriasis Sinocelltech Ltd. 330
Early research (Phase 1)Study completedNCT04316585What this trial is testingEvaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis ParticipantsWho this might be right forPsoriasis GlaxoSmithKline 29
Large-scale testing (Phase 3)Study completedNCT02635204What this trial is testingThe Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Promius Pharma, LLC 267
Not applicableStudy completedNCT01320293What this trial is testingCardiovascular Effects in Psoriasis Patients Treated With Adalimumab.Who this might be right forPsoriasis University of North Carolina, Chapel Hill 18
Large-scale testing (Phase 3)Study completedNCT07008547What this trial is testingTo Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis SPH-BIOCAD (HK) Limited 202
Large-scale testing (Phase 3)Study completedNCT00442650What this trial is testingEfalizumab for Treatment of Patients With Moderate to Severe PsoriasisWho this might be right forModerate to Severe Psoriasis Merck KGaA, Darmstadt, Germany
Large-scale testing (Phase 3)Study completedNCT07746479What this trial is testingEvaluate the Efficacy and Safety of LZM012 ( Psoriasis )Who this might be right forPsoriasis Livzon Pharmaceutical Group Inc. 244
Testing effectiveness (Phase 2)Study completedNCT03101670What this trial is testingAssess Efficacy and Safety of Filgotinib in Active Psoriatic ArthritisWho this might be right forPsoriatic Arthritis Lakefront Biotherapeutics NV 131
Large-scale testing (Phase 3)Study completedNCT04930042What this trial is testingEfficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Alvotech Swiss AG 581
Large-scale testing (Phase 3)Study completedNCT02982005What this trial is testingKHK4827 (Brodalumab) in Subjects With Moderate to Severe Psoriasis in KoreaWho this might be right forModerate to Severe Plaque Psoriasis Kyowa Kirin Korea Co., Ltd. 62
Large-scale testing (Phase 3)Study completedNCT02826603What this trial is testingStudy of Secukinumab Compared to Ustekinumab in Subjects With Plaque PsoriasisWho this might be right forPlaque Psoriasis Novartis Pharmaceuticals 1,114